Endpoints News 生物医药· Kyle LaHucik·· 2026-10-16AI 评分30
Eli Lilly 神经科学负责人称对伊博格aine研发投资感兴趣
Lilly interested in ibogaine investments, its neuro leader says
AI 导读
Eli Lilly 的神经科学负责人卡罗尔·德汉布兰在周四的一场迷幻药会议上表示,该公司对研发“改善伊博格aine特性”的项目感兴趣。
正文
Eli Lilly is interested in R&D efforts to “improve the profile of ibogaine,” the pharma giant’s neuroscience president said at a psychedelics conference Thursday.
Carole …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news